Skip to main content
. 2022 Jan 11;9:814813. doi: 10.3389/fbioe.2021.814813

TABLE 2.

Basic clinical characteristics of PRAD patients in validation cohort.

Characteristic Levels Overall
n 80
T stage, n (%) T2 32 (40%)
T3 40 (50%)
T4 8 (10%)
N stage, n (%) N0 64 (80%)
N1 16 (20%)
M stage, n (%) M0 72 (90%)
M1 8 (10%)
Age, n (%) ≤60 37 (46%)
>60 43 (54%)
OS event, n (%) Alive 64 (80%)
Dead 16 (20%)
Age, median (IQR) 59 (52, 69)